Bacteriocin programs.
Real-world applications.
Advancing internal and partnered programs across animal nutrition, animal health, and pet nutrition.
Developed by Organicin.
Animal Nutrition
Vibrio parahaemolyticus
Field Trial
Targeting Acute Hepatopancreatic Necrosis Disease (AHPND) and Early Mortality Syndrome (EMS).
Our candidate also addresses Translucent Post-Larva Disease (TPD) and White Feces Syndrome, as Vibrio parahaemolyticus is a primary causative agent for these conditions. Demonstrated strong controlled-trial outcomes and is advancing through field validation.
Animal Health
Clostridium perfringens
Develop
A targeted bacteriocin candidate for preventing necrotic enteritis in broiler chickens by inhibiting Clostridium perfringens while preserving microbiome health.
CinThesis co-development.
Confidential Partner
Target Confidential
Phase 2.1 · Development 15% through phase
Developing bacteriocins for animal health.
Confidential Partner
Target Confidential
Phase 0 · Selection 90% through phase
Phase 2.3 · Development 45% through phase
Developing bacteriocins for pet nutrition.
Work with Organicin
We work with partners across animal nutrition, animal health, and adjacent microbiome applications to create bacteriocin-based solutions.
Partner with us Explore CinThesis